Recent Updates
Recently added Catalysts

40/ taken first

Phase 2

Opioid Abuse | Small molecule | Pain |Pfizer, Inc.|Last Updated: Nov 1, 2018

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLEDBiomarker
Total Trials1
Total Enrollment49
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01030406Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid UsersPHASE2 COMPLETED 49Jan 1, 2010Feb 1, 2010Nov 1, 20181 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Drug Liking at .5 Hours
Measure collected at 0.5 hours post-dose

Drug Liking/Disliking Assessment on a 101 point bipolar visual analog scale (VAS) used to assess response to the question "Do you dislike or like the drug effect you are feeling now?" and anchored in the center with "Neither like nor dislike" (score of 50), on the left with "Dislike an awful lot" (score of 0) and on the right with "Like an awful lot" (score of 100).

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingDOUBLE
ModelCROSSOVER
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
40/0mg taken firstACTIVE_COMPARATOR8x oxycodone/niacin 5/0mg tablets
80/0mg taken firstACTIVE_COMPARATOR8x oxycodone/niacin 10/0mg tablets
40/240mg taken firstEXPERIMENTAL8x oxycodone/niacin 5/30mg tablets
80/480mg taken firstEXPERIMENTAL8x oxycodone/niacin 10/60mg tablets
0/0mg taken firstPLACEBO_COMPARATORPlacebo
Interventions
NameTypeDescription
40/0mg taken firstDRUG8x Oxycodone/Niacin 5/0mg tablets All arms taken with a 48 hour washout between doses
80/0mg taken firstDRUG8x Oxycodone/Niacin 10/0mg tablets All arms taken with a 48 hour washout between doses
40/240mg taken firstDRUG8x Oxycodone/Niacin 5/30mg tablets All arms taken with a 48 hour washout between doses
80/480mg taken firstDRUG8x Oxycodone/Niacin 10/60mg tablets All arms taken with a 48 hour washout between doses
0/0mg taken firstDRUGPlacebo All arms taken with a 48 hour washout between doses
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 55 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Subject is male or female between 18 and 55 years old. * Subject is in generally good health, including no history of pulmonary disease, and has a body mass index (BMI) within 18-33 kg/m2. * Subject is a recreational opioid user (i.e., at least 10 occasions within the past 12 ...

Countries:United States
Unlock Eligibility Criteria